(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USOS DE AGONISTAS DE RECEPTOR FARNESOIDE X E MÉTODO PARA DETERMINAR A CANDIDATURA DE UM PACIENTE PARA TRATAMENTO TERAPÊUTICO PARA SAH

Em AnáliseInvention PatentPCT · US2023019448

Application data

Number

112024020331

Type

Invention Patent

Filing

04/21/2023

Publication

01/14/2025

PCT

US2023019448

Progress at the INPI

  1. Filing04/21/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 04/21/2023. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 07/07/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ALFASIGMA S.P.A.

IT

INTERCEPT PHARMACEUTICALS, INC.

US

See this company's full portfolio

Inventors

T. C. (pessoa física)

US

Technical data

Priority claims

US

63/333,287 · 04/21/2022

US

63/381,752 · 10/31/2022

Abstract

USOS DE AGONISTAS DE RECEPTOR FARNESOIDE X A presente invenção refere-se a compostos agonistas de FXR e métodos de uso dos mesmos para tratar, melhorar ou promover a recuperação de doenças e distúrbios, como doenças agudas do fígado, por exemplo, hepatite grave associada ao álcool.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Transferência deferida

#25.1

07/07/2026

RPI 2896

Adição na publicação

#15.35

05/05/2026

RPI 2887

Notificação de entrada na fase nacional - PCT

#1.3

01/14/2025

RPI 2819

Alteração de dados cadastrais

#1.1

10/08/2024

RPI 2805

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.